Genetic testing is covered by insurance in many cases, but coverage depends heavily on the type of test, your specific plan, and whether the test meets your insurer’s definition of “medically necessary.” Most health insurance plans will cover genetic testing when a doctor recommends it and the results would directly influence your treatment. Tests ordered out of curiosity or without a clear clinical reason are far less likely to be covered.
The details vary enough from test to test and plan to plan that it’s worth understanding the landscape before you get a bill you weren’t expecting.
What “Medically Necessary” Means for Coverage
The single biggest factor determining whether your insurance pays for a genetic test is medical necessity. Insurers generally require that the test be ordered by your doctor, that the results will change how you’re treated, and that there’s an established clinical reason for running it. A test that confirms a diagnosis and opens up a specific treatment option is much more likely to be approved than one that provides information without a clear next step.
Many plans also require prior authorization, meaning your doctor’s office submits paperwork explaining why the test is needed before it’s performed. This process can include documentation that you received genetic counseling or that you meet specific risk criteria. If your doctor skips prior authorization on a plan that requires it, you could be responsible for the full cost even if the test would have been approved.
Prenatal Genetic Screening
Non-invasive prenatal testing (NIPT), which screens for chromosomal conditions like Down syndrome using a blood draw from the mother, is one of the most commonly covered genetic tests. Most major insurers now cover NIPT for all singleton pregnancies, not just high-risk ones. UnitedHealthcare, Anthem, Aetna, Cigna, and Centene all cover it for singleton pregnancies, with Anthem, Aetna, and Centene also extending coverage to twin pregnancies.
A few plans still restrict NIPT to high-risk pregnancies only. TRICARE and Molina Healthcare, for instance, cover it only when specific risk factors are present: maternal age of 35 or older at delivery, abnormal ultrasound findings, a prior pregnancy with a chromosomal condition, or a positive result on standard screening. If you’re under 35 with no risk factors and your plan has these restrictions, you may need to pay out of pocket.
Even plans that broadly cover NIPT often require that the pregnancy has reached at least 10 weeks, that you haven’t already had another type of chromosomal screening in the same pregnancy, and that pre-test counseling was documented. Centene’s policy, for example, explicitly requires all of those conditions to be met before the test qualifies as medically necessary.
Cancer Risk and BRCA Testing
Genetic testing for hereditary cancer risk, particularly BRCA1 and BRCA2 mutations linked to breast and ovarian cancer, is widely covered but with important restrictions. Most private insurers cover BRCA testing when you have a personal or family history that suggests elevated risk. The criteria typically include a personal history of breast or ovarian cancer, a close relative with a known BRCA mutation, or a pattern of cancer in your family that fits hereditary profiles.
Medicare takes a narrower approach. It generally covers BRCA testing only for patients who already have signs or symptoms of cancer. Testing unaffected family members, even those with a strong family history, is not a covered service under standard Medicare policy. Once a mutation has been identified in a family, Medicare will cover testing a relative for that specific mutation, but only if that relative also has signs or symptoms of breast cancer.
For patients with advanced cancer, Medicare covers next-generation sequencing (a broad genetic scan of tumor tissue) when the cancer is recurrent, metastatic, or stage III or IV, the patient is considering further treatment, and the test has FDA approval. For inherited cancer testing specifically, Medicare expanded coverage in 2020 to include patients with ovarian or breast cancer who have a clinical indication and risk factor for hereditary cancer. The test must be FDA-approved and the results must be reported back to the treating physician with treatment recommendations.
Pharmacogenomic Testing
Pharmacogenomic tests look at how your genes affect the way you process medications. These tests are sometimes marketed to people starting antidepressants, blood thinners, or other drugs where individual response varies widely. In theory, they could help your doctor pick the right medication faster. In practice, insurance coverage is spotty.
UnitedHealthcare, one of the largest insurers in the country, considers multi-gene pharmacogenomic panels (tests covering five or more genes) “unproven and not medically necessary” for any indication. Their reasoning: clinical practice guidelines for psychiatry don’t endorse these panels, and the evidence that they improve outcomes remains limited. The picture is similar for cardiovascular applications, where high-quality studies showing better results from pharmacogenomic testing are still lacking.
Single-gene pharmacogenomic tests tied to a specific FDA recommendation (such as testing for a gene variant before prescribing a particular drug) are more likely to be covered than broad panels. If your doctor recommends a pharmacogenomic panel, it’s worth calling your insurer first to check whether it’s covered and how much you’d owe if it isn’t.
What Insurance Won’t Cover
Direct-to-consumer genetic tests, like ancestry kits or wellness-oriented DNA reports, are almost never covered by insurance. These tests aren’t ordered by a physician and don’t meet medical necessity criteria. The same goes for most “curiosity” genetic testing where the results won’t change a treatment decision.
Whole-genome sequencing for general health screening, without a specific clinical question, also falls outside most coverage policies. Insurers want a defined reason for the test and a clear connection between the result and a medical action.
Legal Protections Around Genetic Testing
If you’re hesitant about genetic testing because you worry the results could be used against you, federal law offers significant protection, but with gaps. The Genetic Information Nondiscrimination Act (GINA) prohibits health insurers from using genetic information to determine eligibility, set premiums, or make coverage decisions. Health insurers also cannot require you or your family members to undergo genetic testing. These protections apply to private insurers, Medicare, Medicaid, federal employee plans, and the Veterans Health Administration.
GINA also prevents employers with 15 or more employees from using genetic information in hiring, firing, promotions, or pay decisions. Employers can request genetic information for voluntary wellness programs, but they cannot penalize you for declining to share it.
The gap worth knowing about: GINA does not cover life insurance, long-term care insurance, or disability insurance. Companies offering these products can legally ask about genetic test results and use them in their decisions. This is a real consideration if you’re planning to apply for life or long-term care insurance and are weighing whether to get tested first.
How to Check Your Coverage Before Testing
The most reliable approach is to call the number on your insurance card before any genetic test is performed. Ask specifically whether the test requires prior authorization, what clinical criteria must be met, and whether the lab your doctor uses is in-network. Out-of-network labs are a common source of surprise bills even when the test itself is covered.
Your doctor’s office or a genetic counselor can often handle prior authorization on your behalf and will know what documentation your plan requires. If a test is denied, you have the right to appeal. Many denials are overturned when additional clinical documentation is submitted, particularly letters from genetic counselors explaining why the test is medically indicated for your specific situation.
For tests that aren’t covered, many genetic testing companies offer payment plans or reduced self-pay rates that are significantly lower than the list price billed to insurance. It’s worth asking the lab directly about out-of-pocket pricing, which can sometimes be a few hundred dollars even for tests that would be billed at several thousand through insurance.